Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03241004 · ClinicalTrials.gov registry record · NA

Does Melatonin Affect Anesthetic MAC (Minimum Alveolar Concentration)?

A NA study, sponsored by Englewood Hospital and Medical Center.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT03241004: Clinical Trial NA study, sponsored by Englewood Hospital and Medical Center.

NCT03241004 is a NA study that was terminated before completion, run by Englewood Hospital and Medical Center. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03241004, a NA study, was terminated before completion, sponsored by Englewood Hospital and Medical Center.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This study aims to determine if anesthetic depth can be deepened non-pharmacologically through use of sleep masks. This study seeks to demonstrate a relationship between the depth of anesthesia with application of sleep masks intraoperatively and in the critical care setting.

Primary Outcome

change in depth of anesthesia from baseline to two hours

Interventions

  • OTHER Sleep Mask

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2017-07-07
Est. Completion 2021-07-08
Phase NA

Why NCT03241004 stopped before completion

NCT03241004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Sleep Mask is the first listed.

NCT03241004 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03241004 about?

NCT03241004 is a clinical study titled "Does Melatonin Affect Anesthetic MAC (Minimum Alveolar Concentration)?". This study aims to determine if anesthetic depth can be deepened non-pharmacologically through use of sleep masks. This study seeks to demonstrate a relationship between the depth of anesthesia with application of sleep masks intraoperatively and in the critical care setting.

What is the current status of trial NCT03241004?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2017-07-07. Estimated completion is 2021-07-08.

What interventions are being tested in trial NCT03241004?

The interventions under investigation include: Sleep Mask (OTHER).

Who is sponsoring clinical trial NCT03241004?

This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03241004's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03241004, the US trial registry maintained by the National Library of Medicine. NCT03241004 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.